Variables | categories | Status | CHR(95%CI) | AHR(95%CI) | |
---|---|---|---|---|---|
 |  | Event | Censored |  |  |
Age in year | 15–24 | 13 | 65 | 2.02 (0.77–5.33) | 0.67 (0.19–2.35) |
25–34 | 27 | 169 | 1.68 (0.69–4.07) | 1.24 (0.47–3.23) | |
35–44 | 15 | 127 | 1.36 (0.52–.3.50) | 0.80 (0.29–2.21) | |
> = 45 | 6 | 68 | 1 | 1 | |
Sex | Male | 30 | 173 | 1.48 (0.90–2.46) | 1.46 (0.83–2.57) |
Female | 31 | 256 | 1 | 1 | |
Educational status | No education | 15 | 113 | 1 | 1 |
Primary | 22 | 100 | 1.62 (0.84–3.12) | 1.32 (0.64–2.71) | |
Secondary above | 24 | 216 | 0.81 (0.42–1.56) | 0.71 (0.33–1.49) | |
Occupation | Un employed | 19 | 85 | 2.21 (1.23–3.97) | 1.52 (0.73–3.15) |
Employed | 9 | 81 | 1.06 (0.50–2.25) | 1.88 (0.80–4.42) | |
Daily laborer | 5 | 19 | 2.54 (0.99–6.58) | 1.35 (0.49–3.75) | |
Self-employed | 28 | 244 | 1 | 1 | |
CPT | Yes | 32 | 239 | 1 | 1 |
No | 29 | 190 | 1.40 (0.84–2.32) | 1.8 (1.03–3.16)* | |
Baseline functional status | Working | 40 | 345 | 1 | 1 |
Ambulator/bedridden | 21 | 84 | 1.98 (1.16–3.36) | 1.23 (0.65–2.32) | |
Adherence | Good | 32 | 382 | 1 | 1 |
Fair/poor | 29 | 47 | 6.16 (3.7–10) | 5.46 (3.06–9.74)* | |
TB/HIV-co-infection | Yes | 15 | 77 | 1.91 (1.07–3.43) | 1.27 (0.65–2.51) |
No | 46 | 352 | 1 | 1 | |
First-line drug regimen | EFV based | 42 | 395 | 1 | 1 |
NVP based | 19 | 34 | 3.82 (2.22–6.5) | 3.53 (1.73–7.21)* | |
Hemoglobin level | Anemic | 25 | 81 | 2.6 (1.57–4.35) | 1.46 (0.83–2.57) |
Not anemic | 36 | 348 | 1 | 1 | |
Baseline CD4 count | <=200 | 29 | 163 | 2.83 (0.86–9.3) | 3.9 (1.07–13.9)* |
201–350 | 18 | 110 | 2.47 (0.72–8.41) | 4.1 (1.12–15)* | |
351–500 | 11 | 90 | 1.96 (0.54–7.04) | 2.14 (0.54–8.5) | |
> 500 | 3 | 66 | 1 | 1 | |
Baseline WHO stage | Stage I/II | 29 | 275 | 1 | 1 |
Stage III/IV | 32 | 154 | 1.80 (1.1–2.98) | 1.15 (0.61–2.20) | |
Past OI | Yes | 23 | 127 | 1.42 (0.85–2.39) | 1.21 (0.61–2.41) |
No | 38 | 302 | 1 | 1 |